Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2024. The report specifically details a transaction in the company's own shares executed on August 30, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 310,301 ordinary shares
- Purpose: Cancellation under the Buyback Programme
- Highest Price Paid: 384.60 pence per share
- Lowest Price Paid: 379.40 pence per share
- Volume Weighted Average Price: 381.9026 pence per share
- Post-Transaction Share Capital: 9,123,638,944 ordinary shares
Material Changes
The primary material change reported is the reduction in the company's registered share capital following the cancellation of 310,301 shares. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of a completed share transaction in compliance with the Market Abuse Regulation (Article 5s(1)(b)).
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the August 1, 2024 Buyback Programme.
- Confirm the remaining authorized buyback limit and the programme's end date.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction data.
- Check subsequent filings for updates on the company's total share count and capital structure.